Screener
Amphastar Pharmaceuticals AMPH Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Amphastar Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
FAQ
- What is Amphastar Pharmaceuticals's current ratio?
- Amphastar Pharmaceuticals (AMPH) reported current ratio of 2.4× in Q2 2026.
- How has Amphastar Pharmaceuticals's current ratio changed year-over-year?
- Amphastar Pharmaceuticals's current ratio decreased by 27.2% year-over-year, from 3.3× to 2.4×.
- What is the long-term trend for Amphastar Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Amphastar Pharmaceuticals's current ratio has grown at a 10.0% compound annual growth rate (CAGR), from 2.5× to 4×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Amphastar Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude